Cell engineering for muscle gene therapy: Extemporaneous production of retroviral vector packaging macrophages using defective herpes simplex virus type 1 vectors harbouring gag, pol, env genes

Cytotechnology

Volumn 30, Issue 1-3, 1999, Pages 173-180

  Parish, Elaine ^a   Peltékian, Elise ^a   Dickson, George ^b   Epstein, Alberto L ^c   Garcia, Luis ^a  

^a GÉNÉTHON   (France)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c CENTRE DE GÉNÉTIQUE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Gene therapy; HSV1 amplicon; Macrophages; Muscle dystrophy; Retrovirus packaging

Indexed keywords

ABACA; BIOENGINEERING; GENE THERAPY; RETROVIRUS;

EID: 0344242004     PISSN: 09209069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Acsadi G, Dickson G, Love DR, Jani A, Walsh FS, Gurusinghe A, Wolff JA and Davies KE (1991) Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature 352: 815-818.
2. Bilang-Bleuel A, Revah F, Colin P, Locquet I, Robert JJ, Mallet J and Horellou P (1997). Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat mode of Parkinson disease. Proc Natl Acad Sci USA 94(16): 8818-8823.
3. Carlson BM (1986) Regeneration of entire squeletal muscle. Federation Proceedings 45(5): 1456-1460.
4. Crocker PR and Gordon SJ (1989) Mouse macrophage hemagglutinin (sheep erythrocyte receptor) with specificity for sialylated glycoconjugates characterized by a monoclonal antibody. Exp Med 169(4): 1332-1345.
5. Deconinck N, Ragot T, Marechal G, Perricaudet M and Gillis JM (1996) Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene. Proc Natl Acad Sci USA 93(8): 3570-3574.
6. Emery A, Duchenne Muscular Dystrophy, Oxford University Press, 1993.
7. Erbacher P, Bousser MT, Raimond J, Monsigny M, Midoux P and Roche AC (1996) Gene transfer by DNA/glycosylated polylysine complexes into human blood monocyte-derived macrophages. Hum Gene Ther 7(6): 721-729.
8. Fassati A, Wells DJ, Walsh FS and Dickson G (1996) Transplantation of retroviral producer cells for in vivo gene transfer into mouse skeletal muscle. H Gene Therapy 7(5): 595-602.
9. Fassati A, Wells DJ, Sgro Serpente PA, Walsh FS, Brown SC, Strong PN and Dickson G (1997) Genetic correction of dystrophin deficiency and skeletal muscle remodeling in adult MDX mouse via transplantation of retroviral producer cells J Clin Invest 100(3): 620-628.
10. Fraefel C, Song S, Lim F, Lang P, Yu L, Wang Y, Wild P and Geller Al (1996) Helper virus-free transfer of herpes simplex virustype 1 plasmid vectors into neural cells J Virol 70(10): 7190-7197.
11. Haddada H, Lopez M, Martinache C, Ragot T, Abina MA and Perricaudet M (1993) Efficient adenovirus-mediated gene transfer into human blood monocyte-derived macrophages. Biochem Biophys Res Commun 195(3): 1174-1183.
12. Huang S, Endo Rl and Nemerow GR (1995) Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery. J Virol 69(4): 2257-2263.
13. Jacoby DR, Fraefel C and Breakefield XO (1997) Hybrid vectors a new generation of virus-based vectors designed to control the cellular fate of delivered genes Gene Therapy 4(12): 1281-1283.
14. Kristoffersen AK, Sindre H, Mandi Y, Rollag H and Degre M (1997) Effect of adenovirus 2 on cellular gene activation in blood-derived monocytes and macrophages APMIS 105(5): 402-409.
15. Lawrence MS, Ho DY, Sun GH, Steinberg GK and Sapolsky RM (1996) Overexpression of Bcl-2 with herpessimplex virus vec-tors protects CNS neurons against neurological insults in vitro and in vivo. J Neurosci 16(2): 486-496.
16. Le Gal La Salle G, Robert JJ, Berrard S, Ridoux V, Stratford-Perricaudet LD, Perricaudet M and Mallet J (1993) An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259(5097): 988-990.
17. Lowenstein PR, Fournel S, Bain D, Tomasec P, Clissold P, Castro MG and Epstein A (1994) Herpes simplex virus 1 (HSV-1) helper co-infection affects the distribution of an amplicon encoded protein in glia. Neuroreport 5(13): 1625-1630.
18. Miller AD and Rosman GJ (1989) Improved retroviral vectors for gene transfer and expression. BioTechniques 7(9): 980-982.
19. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM and Trono D (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272(50259): 263-267.
20. Orimo S, Hiyamuta E, Arahata K and Sugita H (1991) Analysis of inflammatory cells and complement C3 in bupivacaine-induced myonecrosis Muscle and Nerve 14(6): 515-520.
21. Parrish EP, Cifuentes-Diaz C, Li ZL, Vicart P, Paulin D, Dreyfus PA, Peschanski M, Harris AJ and Garcia L (1996) Targeting widespread sites of damage in dystrophic muscle: engrafted macrophages as potential shuttles. Gene Therapy 3(1): 13-20.
22. Peel AL, Zolotukhin S, Schrimsher GW, Muzyczka N and Reier PJ (1997) Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters. Gene Therapy 4(1): 16-24.
23. Quantin B, Perricaudet LD, Tajbakhsh S and Mandel JL (1992) Adenovirus as an expression vector in muscle cells in vivo. Proc Natl Acad Sci USA 89(7): 2581-2584.
24. Ragot T, Vincent N, Chafey P, Vigne E, Gilgenkrantz H, Couton D, Cartaud J, Briand P, Kaplan JC, Perricaudet M. et al. (1993) Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361 (60413): 647-650.
25. Savard N, Cosset FL and Epstein AL (1997) Defective herpes simplex virus type 1 vectors harboring gag, pol, and env genes can be used to rescue defective retrovirus vectors J Virol 71(5): 4111-4117.
26. Schultz E and Lipton PH (1980) Mech Aging Dev 13:105-112.
27. Smith MJ and Koch GLE (1987) Differential expression of murine macrophage surface glycoprotein antigens in intracellular membranes J Cell Sci 87(Pt1): 113-119.
28. Snyder RO, Miao CH, Patijn GA, Spratt SK, Danos O, Nagy D, Gown AM, Winther B, Meuse L, Cohen LK, Thompson AR and Kay MA (1997) Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors Nat Genet 16(3): 270-276.
29. Snyder RO, Spratt SK, Lagarde C, Bohl D, Kaspar B, Sloan B, Cohen LK and Danos O (1997) Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice. Hum Gene Ther 8(16): 1891-1900.
30. Spaete RR and Frenkel N (1982) The herpes simplex virus amplicon: a new eucaryotic defective-virus cloning-amplifying vector. Cell 30(1): 295-304.
31. Vicart P, Schwartz B, Vandewalle A, Bens M, Delouis C, Panthier JJ, Pournin S, Babinet C and Paulin D (1994) Immortalization of multiple cell types from transgenic mice using a transgene containing the vimentin promoter and a conditional oncogene. Exp Cell Res 214(1): 35-45.
32. Weir JP, Dacquel EJ and Aronovitz J (1996) Herpesvirus vector-mediated gene delivery to human monocytes Hum Gene Ther 7(11): 1331-1338.
33. Vincent N, Ragot T, Gilgenkrantz H, Couton D, Chafey P, Gregoire A, Briand P, Kaplan JC, Kahn A and Perricaudet M (1993) Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a mi ni dystrophin gene. Nature Genet 5(2): 130-134.
34. Wickham TJ, Tzeng E, Shears LL 2nd, Roelvink PW, Li Y, Lee GM, Brough DE, Lizonova A and Kovesdi I (1997) Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins J Virol 71(11): 8221-8229.
35. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A and Feigner PL (1990) Direct gene transfer into mouse muscle in vivo. Science 245(4949): 1465-1468.